Immunosuppressive Agents: all 5,940 studies that test it
Page 55 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Sirolimus in Combination With TacrolimusStatus unknownNCT00141804Phase 3
- Study Evaluating Etanercept in Moderate to Severe AsthmaCompletedNCT00141791Phase 2
- The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host DiseaseCompletedNCT00141713Phase 2
- Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular DegenerationCompletedNCT00140803Phase 2
- Phase II Study Using Thalidomide for the Treatment of ALSCompletedNCT00140452Phase 2
- Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric SubjectsCompletedNCT00139581Phase 4
- Effects of Cyclosporine A on Pancreatic Insulin SecretionCompletedNCT00139035Phase 4
- Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following TransplantationCompletedNCT00139009Phase 4
- Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic MelanomaTerminatedNCT00138229Phase 2
- Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant RecipientsTerminatedNCT00137345Phase 3
- Treatment of Patients With Idiopathic Membranous NephropathyCompletedNCT00135954Phase 3
- Study of Etanercept (Enbrel) in the Treatment of Pemphigus VulgarisCompletedNCT00135720Phase 2
- Etanercept With Tacrolimus for PsoriasisCompletedNCT00134394Phase 2
- Study of the Efficacy and Safety of Etanercept in Adults With VitiligoCompletedNCT00134368Phase 2
- TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant RecipientsCompletedNCT00133887Phase 3
- Study of Unrelated Cord Blood Transplantation Using Tacrolimus and SirolimusCompletedNCT00133367Phase 2
- Effect of Rapid Steroid Withdrawal on Subclinical Markers of RejectionTerminatedNCT00133172Phase 4
- COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)CompletedNCT00132899Phase 3
- Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid DisordersCompletedNCT00132418Phase 4
- Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.Status unknownNCT00131313Phase 4
- Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)Status unknownNCT00131053Phase 2
- High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)Status unknownNCT00131027Phase 3
- Efficacy of Elidel Cream on Erosive Oral Lichen PlanusCompletedNCT00130572Phase 3
- Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic DermatitisCompletedNCT00130364Phase 4
- Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early AbortionCompletedNCT00129506Phase 4
- Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated VasculitisTerminatedNCT00128895Phase 4
- Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis SiccaCompletedNCT00128245Phase 2
- Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and CachexiaTerminatedNCT00127387Phase 2/3
- Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)Status unknownNCT00126321Phase 2
- Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaTerminatedNCT00126243Phase 2
- Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous NephritisCompletedNCT00125307Phase 4
- Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple MyelomaStatus unknownNCT00124813Phase 2
- Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00124280Phase 2
- A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast CancerCompletedNCT00124111Phase 2
- BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' DiseaseCompletedNCT00123916Phase 3
- Study of Etanercept in the Treatment of Psoriasis in Adult SubjectsCompletedNCT00121615Phase 3
- Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic DermatitisCompletedNCT00121381Phase 4
- Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsCompletedNCT00121316Phase 4
- Quality of Life Study in Adults With Facial EczemaCompletedNCT00120302Phase 4
- Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00119340Phase 1/2
- Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent OsteosarcomaCompletedNCT00119301Phase 1
- Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and EverolimusTerminatedNCT00117702Phase 2/3
- Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionCompletedNCT00117689Phase 2
- Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic DermatitisCompletedNCT00117377Phase 4
- Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With PsoriasisCompletedNCT00116181Phase 3
- Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)CompletedNCT00115414Phase 2
- Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)CompletedNCT00115219Phase 4
- Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00114192Phase 2
- Imuran Dosing in Crohn's Disease StudyTerminatedNCT00113503Phase 2
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple MyelomaWithdrawnNCT00112879Phase 2
- Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00112567Phase 1/2
- AVONEX® Combination Trial - "ACT"CompletedNCT00112034Phase 4
- Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic SyndromeCompletedNCT00111956Phase 2/3
- UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory PatientsCompletedNCT00111748Phase 3
- Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisCompletedNCT00111449Phase 3
- Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult SubjectsCompletedNCT00111436Phase 3
- Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and AdolescentsStatus unknownNCT00111345Phase 2/3
- Enbrel® in Psoriatic ArthritisCompletedNCT00111124Phase 4
- An Evaluation of Etanercept in the Treatment of Subjects With PsoriasisCompletedNCT00111111Phase 3
- Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of PsoriasisCompletedNCT00110981Phase 4
- Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral RetinoblastomaActive, not recruitingNCT00110110Phase 2
- Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00110071Phase 1
- Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous LeukemiaCompletedNCT00110058Phase 2
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple SclerosisCompletedNCT00109161Phase 2
- Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal WomenCompletedNCT00107016Phase 2
- A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisCompletedNCT00106496Phase 4
- Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel BlockageCompletedNCT00106132Phase 3
- Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser PhotocoagulationCompletedNCT00105404Phase 3
- S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00104988Phase 2
- Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
- Effect of Leflunomide on T Cell Proliferation in HIV-Infected PatientsCompletedNCT00101374Phase 1
- Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular DegenerationCompletedNCT00100009Phase 3
- Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney TransplantCompletedNCT00099801Phase 3
- Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney TransplantCompletedNCT00099749Phase 2/3
- Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantCompletedNCT00099736Phase 3
- Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)CompletedNCT00099554Phase 4
- Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantationCompletedNCT00098735Phase 3
- Everolimus in Treating Patients With Stage IV MelanomaCompletedNCT00098553Phase 2
- Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00098462Phase 1/2
- Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant PatientsCompletedNCT00098241Phase 3
- Imuran (Azathioprine) Dose-Ranging Study in Crohn's DiseaseTerminatedNCT00098111Phase 3
- A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) PatientsCompletedNCT00098007Phase 3
- Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft VasculopathyCompletedNCT00097968Phase 3
- Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00096096Phase 2
- Treating Multiple Sclerosis With Sirolimus, an Immune System SuppressorTerminatedNCT00095329Phase 1/2
- Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)CompletedNCT00094380Phase 1/2
- Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled SyringesCompletedNCT00094341Phase 4
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast CancerCompletedNCT00093834Phase 1
- Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi AnemiaCompletedNCT00093743Phase 1
- Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib MesylateCompletedNCT00093639Phase 1/2
- Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaStatus unknownNCT00093587Not applicable
- Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney CancerStatus unknownNCT00093522Phase 2
- Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNCT00093366Phase 1/2
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected SubjectsCompletedNCT00091741Phase 1
- Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic MelanomaCompletedNCT00091143Phase 1
- Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic MelanomaCompletedNCT00091104Phase 1
- Study of LJP 394 in Lupus Patients With History of Renal DiseaseTerminatedNCT00089804Phase 3
- A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00089726Phase 2
- Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00089349Phase 2